Coverart for item
The Resource The new profile of drug-resistant tuberculosis in Russia : a global and local perspective : summary of a joint workshop by the Institute of Medicine and the Russian Academy of Medical Science, Steve Olsen, Rebecca English, and Anne Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies and Russian Academy of Medical Sciences, (electronic resource)

The new profile of drug-resistant tuberculosis in Russia : a global and local perspective : summary of a joint workshop by the Institute of Medicine and the Russian Academy of Medical Science, Steve Olsen, Rebecca English, and Anne Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies and Russian Academy of Medical Sciences, (electronic resource)

Label
The new profile of drug-resistant tuberculosis in Russia : a global and local perspective : summary of a joint workshop by the Institute of Medicine and the Russian Academy of Medical Science
Title
The new profile of drug-resistant tuberculosis in Russia
Title remainder
a global and local perspective : summary of a joint workshop by the Institute of Medicine and the Russian Academy of Medical Science
Statement of responsibility
Steve Olsen, Rebecca English, and Anne Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies and Russian Academy of Medical Sciences
Contributor
Subject
Language
eng
Summary
  • An estimated 2 billion people, one third of the global population, are infected with Mycobacterium tuberculosis, the bacterium that causes tuberculosis. Spread through the air, this infectious disease killed 1.7 million in 2009, and is the leading killer of people with HIV. Tuberculosis (TB) is also a disease of poverty--the vast majority of tuberculosis deaths occur in the developing world. Exacerbating the devastation caused by TB is the growing threat of drug-resistant forms of the disease in many parts of the world. Drug-resistant tuberculosis presents a number of significant challenges in terms of controlling its spread, diagnosing patients quickly and accurately, and using drugs to treat patients effectively. In Russia in recent decades, the rise of these strains of TB, resistant to standard antibiotic treatment, has been exacerbated by the occurrence of social, political, and economic upheavals. The Institute of Medicine (IOM) Forum on Drug Discovery, Development, and Translation, in conjunction with the Russian Academy of Medical Sciences held a workshop to discuss ways to fight the growing threat of drug-resistant TB. This book presents information from experts on the nature of this threat and how it can be addressed by exploring various treatment and diagnostic options
  • An estimated 2 billion people, one third of the global population, are infected with Mycobacterium tuberculosis, the bacterium that causes tuberculosis. Spread through the air, this infectious disease killed 1.7 million in 2009, and is the leading killer of people with HIV. Tuberculosis (TB) is also a disease of poverty--the vast majority of tuberculosis deaths occur in the developing world. Exacerbating the devastation caused by TB is the growing threat of drug-resistant forms of the disease in many parts of the world. Drug-resistant tuberculosis presents a number of significant challenges in terms of controlling its spread, diagnosing patients quickly and accurately, and using drugs to treat patients effectively. In Russia in recent decades, the rise of these strains of TB, resistant to standard antibiotic treatment, has been exacerbated by the occurrence of social, political, and economic upheavals. The Institute of Medicine (IOM) Forum on Drug Discovery, Development, and Translation, in conjunction with the Russian Academy of Medical Sciences held a workshop to discuss ways to fight the growing threat of drug-resistant TB. This book presents information from experts on the nature of this threat and how it can be addressed by exploring various treatment and diagnostic options
  • An estimated 2 billion people, one third of the global population, are infected with Mycobacterium tuberculosis, the bacterium that causes tuberculosis. Spread through the air, this infectious disease killed 1.7 million in 2009, and is the leading killer of people with HIV. Tuberculosis (TB) is also a disease of poverty--the vast majority of tuberculosis deaths occur in the developing world. Exacerbating the devastation caused by TB is the growing threat of drug-resistant forms of the disease in many parts of the world. Drug-resistant tuberculosis presents a number of significant challenges in terms of controlling its spread, diagnosing patients quickly and accurately, and using drugs to treat patients effectively. In Russia in recent decades, the rise of these strains of TB, resistant to standard antibiotic treatment, has been exacerbated by the occurrence of social, political, and economic upheavals. The Institute of Medicine (IOM) Forum on Drug Discovery, Development, and Translation, in conjunction with the Russian Academy of Medical Sciences held a workshop to discuss ways to fight the growing threat of drug-resistant TB. This book presents information from experts on the nature of this threat and how it can be addressed by exploring various treatment and diagnostic options
  • An estimated 2 billion people, one third of the global population, are infected with Mycobacterium tuberculosis, the bacterium that causes tuberculosis. Spread through the air, this infectious disease killed 1.7 million in 2009, and is the leading killer of people with HIV. Tuberculosis (TB) is also a disease of poverty--the vast majority of tuberculosis deaths occur in the developing world. Exacerbating the devastation caused by TB is the growing threat of drug-resistant forms of the disease in many parts of the world. Drug-resistant tuberculosis presents a number of significant challenges in terms of controlling its spread, diagnosing patients quickly and accurately, and using drugs to treat patients effectively. In Russia in recent decades, the rise of these strains of TB, resistant to standard antibiotic treatment, has been exacerbated by the occurrence of social, political, and economic upheavals. The Institute of Medicine (IOM) Forum on Drug Discovery, Development, and Translation, in conjunction with the Russian Academy of Medical Sciences held a workshop to discuss ways to fight the growing threat of drug-resistant TB. This book presents information from experts on the nature of this threat and how it can be addressed by exploring various treatment and diagnostic options
Cataloging source
BTCTA
LC call number
RA644.T7
LC item number
N39 2011
NLM call number
  • 2011 I-710
  • WF 200
http://library.link/vocab/relatedWorkOrContributorDate
1956-
http://library.link/vocab/relatedWorkOrContributorName
  • Olson, Steve
  • English, Rebecca A
  • Claiborne, Anne B
  • Institute of Medicine (U.S.)
  • Rossiĭskai?a︡ akademii?a︡ medit?s︡inskikh nauk
http://library.link/vocab/subjectName
  • Tuberculosis, Multidrug-Resistant
  • Antitubercular Agents
  • Tuberculosis
  • Russia
Label
The new profile of drug-resistant tuberculosis in Russia : a global and local perspective : summary of a joint workshop by the Institute of Medicine and the Russian Academy of Medical Science, Steve Olsen, Rebecca English, and Anne Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies and Russian Academy of Medical Sciences, (electronic resource)
Instantiates
Publication
Bibliography note
Includes bibliographical references (p.109-111)
Control code
OCM1bookssj0000539524
Dimensions
unknown
Isbn
9780309162975
Specific material designation
remote
System control number
(WaSeSS)bookssj0000539524
Label
The new profile of drug-resistant tuberculosis in Russia : a global and local perspective : summary of a joint workshop by the Institute of Medicine and the Russian Academy of Medical Science, Steve Olsen, Rebecca English, and Anne Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies and Russian Academy of Medical Sciences, (electronic resource)
Publication
Bibliography note
Includes bibliographical references (p.109-111)
Control code
OCM1bookssj0000539524
Dimensions
unknown
Isbn
9780309162975
Specific material designation
remote
System control number
(WaSeSS)bookssj0000539524

Library Locations

    • Thomas Jefferson LibraryBorrow it
      1 University Blvd, St. Louis, MO, 63121, US
      38.710138 -90.311107
Processing Feedback ...